Company: RGNT
Filing Date: 2025-10-24
Form Type: F-1/A
Source: 0001213900-25-101900
Chunk: 195

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-10-24
Form: F-1/A
Chunk 195
---
 Representative does not exercise its option to purchase additional Ordinary Shares).

All of our Ordinary Shares
have identical voting and other rights in all respects. All of our issued and outstanding Ordinary Shares are duly authorized, validly
issued, fully paid and non-assessable. Our amended and restated articles of association to be in effect upon completion of this offering
and the laws of the State of Israel do not restrict the ownership or voting of Ordinary Shares by non-residents of Israel, except with
respect to citizens of countries that are, or have been, in a state of war with Israel.

Preferred Shares

Upon the consummation of
this offering and the effectiveness of our amended and restated certificate of incorporation that will become effective immediately prior
to the consummation of this offering, we will have no authorized or outstanding preferred shares.

Each currently outstanding
Series A Preferred Share, Series B Preferred Share, Series C Preferred Share, Series D-1 Preferred Share and Series D-2 Preferred Share,
each a Preferred Share, is convertible, at the option of the holder at any time, and without the payment of additional consideration
by the holder into the number of Ordinary Shares as is determined by dividing the original issue price for such Preferred Share by the
conversion price that is in effect at the time of conversion. The initial conversion price is the original issue price for such Preferred
Shares. The original issue price for each Preferred Share is as follows: Series A Preferred Share was $5.00 per share, Series B Preferred
Share was $11.20 per share, Series C Preferred Share was $11.49 per share, Series D-1 Preferred Share was $20.27 per share and Series
D-2 Preferred Share was $15.20 per share, or Original Issue Price. The applicable conversion price of each is subject to adjustment upon
any future stock splits or combinations, dividends and distributions, recapitalizations, or upon the issuance of any new securities as
a price per share lower than the applicable conversion price of the Preferred Shares in effect immediately prior to such issuance.

All outstanding Preferred
Shares will automatically be converted into fully paid and nonassessable Ordinary Shares, at the conversion price at the time in effect
for such Preferred Shares, upon the consummation of this offering.

Registration Number and Purposes of the Company

Our purpose as set forth
in our amended and restated articles of association is to engage in any lawful activity. Our Israeli company number is 513585240. The
address of